ACAT inhibitor (IC50= 3.3 μM). Inhibits cholesterol esterification and reduces plasma cholesterol levels in rats. Also inhibits tumor growth and prolongs survival time in a melanoma mouse model and reduces tumor growth and metastasis in a pancreatic cance
Legal Information
Sold for only research purposes
Storage Temp
Store at -20°C
Shipped In
Ice chest + Ice pads
Product Description
Avasimibe inhibits ACAT with IC50 of 3.3 μM, also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9 μM, 13.9 μM and 26.5 μM, respectively. A cholesterol reducing compound that also inhibits CYP